Guinan, PD, Vogelzang, NJ, Fremgen, AM, Chmiel, JS, Sylvester, JL, Sener, SF, Imperato, JP (1995) Renal cell carcinoma: tumor size, stage and survival. Members of the Cancer Incidence and End Results Committee. J Urol 153: pp. 901-903...
Signs of renal cell cancer include blood in the urine and a lump in the abdomen. Tests that examine the abdomen and kidneys are used to diagnose renal cell cancer. After renal cell cancer has been diagnosed, tests are done to find out if cancer cells have spread within the kidney or to...
Systemic treatments for metastatic clear cell RCC Guidelines for the treatment of kidney cancer recommend the use of these drugs as first-line therapy for metastatic RCC disease. In the event of that one of these therapies doesn’t work, an alternate drug can be given. ...
Renal cell cancer (RCC) is increasingly diagnosed at an early stage in many countries, which likely contributes to the recent leveling of RCC mortality in the United States and many European countries. However, over all stages nearly 50% of the patients die within 5 years after diagnosis. Smok...
Design: IHC for GLUT1 was performed on formalin-fixed, paraffin- embedded tissue samples from kidney biopsies with the following diagnoses: normal (3), thrombotic microangiopathy (TMA, 4), pauci- immune glomerulonephritis (2), sickle cell nephropathy (2), and diabetic nephropathy (3). Immuno...
[44,45,46]. Senescent cells secrete MMP3, which in turn promotes tumor cell invasion and angiogenesis [47]. Furthermore, the SASP facilitates the transition from epithelial to mesenchymal cells, a transformation involved in the progression of metastatic cancer [48]. SASP constituents secreted by ...
Fornara P. Nephron-sparing surgery in renal cell carcinoma: Did we sacrifice too many kidneys in the past? Eur Urol 2007;51:1475-6.Nephron-sparing surgeryin renal cell carcinoma:Did we sacrifice too many kidneysinthe past. Paolo F. European Urolo-gy . 2007...
kidney tumors are being diagnosed at earlier stages, often times incidentally while the patient is still asymptomatic. Nonetheless, at the time of presentation, 40% of these tumors will no longer be confined to the kidney, either through
Intragraft IL-6 mRNA expression by non-resident inflammatory cells and various resident cells in the kidney may promote rejection and tissue injury and as such, may provide a potential therapeutic target in both cell-mediated and antibody-mediated rejection. 1673 Impact of Insufficient Renal Biopsy ...
Renal cell carcinoma (RCC) is a urologic malignancy that originates in the renal tubular epithelium. It is the most prevalent type of kidney cancer and one of the 10 most common cancers diagnosed among men and women worldwide1. Current therapeutic approaches for RCC include robotic-assisted surg...